146 related articles for article (PubMed ID: 17027002)
1. Expressions of Rac1, Tiam1 and Cdc42 in retinoblastoma.
Adithi M; Venkatesan N; Kandalam M; Biswas J; Krishnakumar S
Exp Eye Res; 2006 Dec; 83(6):1446-52. PubMed ID: 17027002
[TBL] [Abstract][Full Text] [Related]
2. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
[TBL] [Abstract][Full Text] [Related]
3. Expression of high mobility group A2 protein in retinoblastoma and its association with clinicopathologic features.
Venkatesan N; Kandalam M; Pasricha G; Sumantran V; Manfioletti G; Ono SJ; Reddy MA; Krishnakumar S
J Pediatr Hematol Oncol; 2009 Mar; 31(3):209-14. PubMed ID: 19262251
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma: expression of HLA-G.
Adithi M; Kandalam M; Ramkumar HL; Subramanian A; Venkatesan N; Krishnakumar S
Ocul Immunol Inflamm; 2006 Aug; 14(4):207-13. PubMed ID: 16911982
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma.
Yang W; Lv S; Liu X; Liu H; Yang W; Hu F
Jpn J Clin Oncol; 2010 Nov; 40(11):1053-9. PubMed ID: 20522449
[TBL] [Abstract][Full Text] [Related]
6. The study of c-Src kinase and pStat3 protein expression in retinoblastoma.
Mohan A; Mallikarjuna K; Venkatesan N; Abhyankar D; Parikh PM; Krishnakumar S
Exp Eye Res; 2006 Oct; 83(4):736-40. PubMed ID: 16716300
[TBL] [Abstract][Full Text] [Related]
7. Histopathological features and P-glycoprotein expression in retinoblastoma.
Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
[TBL] [Abstract][Full Text] [Related]
8. Activated Vav2 modulates cellular invasion through Rac1 and Cdc42 in oral squamous cell carcinoma.
Lai SY; Ziober AF; Lee MN; Cohen NA; Falls EM; Ziober BL
Oral Oncol; 2008 Jul; 44(7):683-8. PubMed ID: 17996485
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.
Deepa PR; Nalini V; Mallikarjuna K; Vandhana S; Krishnakumar S
Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119
[TBL] [Abstract][Full Text] [Related]
10. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas.
Mu G; Liu H; Zhou F; Xu X; Jiang H; Wang Y; Qu Y
Hum Pathol; 2010 Apr; 41(4):493-502. PubMed ID: 20004941
[TBL] [Abstract][Full Text] [Related]
11. Nm23 expression in retinoblastoma.
Krishnakumar S; Lakshmi A; Shanmugam MP; Vanitha K; Biswas J
Ocul Immunol Inflamm; 2004 Jun; 12(2):127-35. PubMed ID: 15512982
[TBL] [Abstract][Full Text] [Related]
12. The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression.
Minard ME; Kim LS; Price JE; Gallick GE
Breast Cancer Res Treat; 2004 Mar; 84(1):21-32. PubMed ID: 14999151
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer.
Kamai T; Yamanishi T; Shirataki H; Takagi K; Asami H; Ito Y; Yoshida K
Clin Cancer Res; 2004 Jul; 10(14):4799-805. PubMed ID: 15269155
[TBL] [Abstract][Full Text] [Related]
14. Expression of Fas ligand in retinoblastoma.
Krishnakumar S; Kandalam M; Mohan A; Iyer A; Venkatesan N; Biswas J; Shanmugam MP
Cancer; 2004 Oct; 101(7):1672-6. PubMed ID: 15378505
[TBL] [Abstract][Full Text] [Related]
15. The role of nitric oxide synthases and nitrotyrosine in retinoblastoma.
Adithi M; Nalini V; Krishnakumar S
Cancer; 2005 Apr; 103(8):1701-11. PubMed ID: 15754329
[TBL] [Abstract][Full Text] [Related]
16. Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1.
Stebel A; Brachetti C; Kunkel M; Schmidt M; Fritz G
Oncol Rep; 2009 Jan; 21(1):217-22. PubMed ID: 19082465
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of Tiam1 and Rac1 overexpression in nasopharyngeal carcinoma.
Qi Y; Huang B; Yu L; Wang Q; Lan G; Zhang Q
ORL J Otorhinolaryngol Relat Spec; 2009; 71(3):163-71. PubMed ID: 19506399
[TBL] [Abstract][Full Text] [Related]
18. The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism.
Uhlenbrock K; Eberth A; Herbrand U; Daryab N; Stege P; Meier F; Friedl P; Collard JG; Ahmadian MR
J Cell Sci; 2004 Sep; 117(Pt 20):4863-71. PubMed ID: 15340013
[TBL] [Abstract][Full Text] [Related]
19. Dock6, a Dock-C subfamily guanine nucleotide exchanger, has the dual specificity for Rac1 and Cdc42 and regulates neurite outgrowth.
Miyamoto Y; Yamauchi J; Sanbe A; Tanoue A
Exp Cell Res; 2007 Feb; 313(4):791-804. PubMed ID: 17196961
[TBL] [Abstract][Full Text] [Related]
20. The Rac activator Tiam1 is required for (alpha)3(beta)1-mediated laminin-5 deposition, cell spreading, and cell migration.
Hamelers IH; Olivo C; Mertens AE; Pegtel DM; van der Kammen RA; Sonnenberg A; Collard JG
J Cell Biol; 2005 Dec; 171(5):871-81. PubMed ID: 16330714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
